Articles by Charlotte Charpentier, PharmD, PhD

Long-Term Efficacy and Safety of Raltegravir, Etravirine, and Darunavir/Ritonavir in Treatment-Experienced Patients: Week 96 Results From the ANRS 139 TRIO Trial

Fagard, Catherine; Colin, Céline; Charpentier, Charlotte; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 59(5):489-493, April 15, 2012.

Impact of Adding Enfuvirtide to the Predictive Value of the Darunavir Genotypic Resistance Score

Charpentier, Charlotte; Lambert-Niclot, Sidonie; Larrouy, Lucile; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(1):e15-e17, May 1, 2011.

Impact of HIV-1 Group O Genetic Diversity on Genotypic Resistance Interpretation by Algorithms Designed for HIV-1 Group M

Depatureaux, Agnès; Charpentier, Charlotte; Leoz, Marie; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 56(2):139-145, February 1, 2011.

High Prevalence of Antiretroviral Drug Resistance Mutations in HIV-1 Non-B Subtype Strains From African Children Receiving Antiretroviral Therapy Regimen According to the 2006...

Gody, Jean-Chrysostome; Charpentier, Charlotte; Mbitikon, Olivia; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 49(5):566-569, December 2008.

Increased Polymorphism in the HR-1 gp41 env Gene Encoding the Enfuvirtide (T-20) Target in HIV-1 Variants Harboring Multiple Antiretroviral Drug Resistance Mutations in the pol...

Si-Mohamed, Ali; Piketty, Christophe; Tisserand, Pascaline; More

JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(1):1-5, January 1, 2007.